VOPTICA S.L.

Their core work

VOPTICA is a Spanish technology SME specializing in visual optics and photonics instrumentation for ophthalmology. Their core work involves developing optical systems that measure and correct the way the human eye focuses light — particularly relevant after cataract or refractive surgery, when standard lenses leave patients with residual visual errors. They bridge high-precision photonics engineering and clinical eye care, producing tools that help surgeons and patients achieve better visual outcomes. Their involvement in both a European research training network (myopia science) and a commercial SME instrument grant signals a company that is grounded in fundamental vision science while pushing toward market-ready diagnostic and corrective devices.

What they specialise in

How they've shifted over time

VOPTICA's two projects span 2016–2020 and tell a coherent story of moving from research participation toward commercial product leadership. Their first project (MyFUN, 2016) placed them inside an academic consortium studying the biology of myopia, signaling a company that wants deep scientific grounding. Their second project (BeVision, 2017) saw them step up as coordinator of a high-value SME instrument grant, indicating that by 2017 they had a product concept mature enough to lead a commercial development effort. The trajectory is clearly from science-adjacent participant to market-facing technology developer.

VOPTICA is moving toward commercialization of ophthalmic photonics hardware — future collaborations would likely center on clinical validation, regulatory pathways (MDR), or integration with surgical planning workflows.

How they like to work

VOPTICA is comfortable in both leadership and partnership roles: they coordinated their highest-value project while joining as a specialist partner in a larger research consortium. Their small network (8 partners across 4 countries) suggests selective, purposeful teaming rather than broad consortium building. For a potential partner, this means they will likely want a defined technical role and real decision-making input — not a seat-filler position.

VOPTICA has worked with 8 unique partners spread across 4 countries, a lean but international footprint typical of focused SMEs in medical devices. Their network spans both academic research institutions (via MyFUN) and commercial/clinical partners (via BeVision), giving them credibility on both sides of the research-to-market divide.

What sets them apart

VOPTICA occupies a rare niche as a Spanish SME that combines rigorous visual science research experience with the demonstrated ability to lead an EU SME Instrument Phase 2 grant — one of the most competitive funding lines in Horizon 2020. This positions them as a credible technical anchor for consortia targeting ophthalmic innovation, particularly where academic partners need an industrially grounded coordinator. Unlike university ophthalmology groups, they bring a product-development mindset; unlike large medtech firms, they remain agile and accessible as a collaboration partner.

Highlights from their portfolio

• BeVision
  Coordinated SME Instrument Phase 2 grant worth €1.74M — one of Horizon 2020's most competitive single-company awards — targeting a direct clinical problem in post-surgical vision, demonstrating both technical maturity and commercial ambition.
• MyFUN
  Participation in a Marie Curie Innovative Training Network on myopia fundamentals shows VOPTICA's scientific depth and their value as an industry bridge in academic research consortia.